Nan Fung Trinity (Hk) LTD Gilead Sciences, Inc. Transaction History

Nan Fung Trinity (Hk) LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$63.15 - $72.88 $8.44 Million - $9.74 Million	133,700 New	133,700 $9.17 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $5.45 Million - $6.98 Million	-86,959 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $5.36 Million - $5.89 Million	86,959 New	86,959 $5.65 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Nan Fung Trinity (Hk) LTD, based on Form 13F filings with the SEC.

Stay updated on Nan Fung Trinity (Hk) LTD with notifications on news.